Similar articles for PMID: 30807397

Year	Number of Results
2004	6
2005	5
2006	7
2007	11
2008	6
2009	6
2010	6
2011	3
2012	10
2013	9
2014	8
2015	9
2016	9
2017	5
2018	9
2019	19
2020	17
2021	7
2022	9
2023	4
2024	0

1

Myeloid Neoplasm With Eosinophilia and FIP1L1-PDGFRA Rearrangement Treated With Imatinib Mesylate: A Pediatric Case With Long-term Follow-up.

Srinivasan A, Scordino T, Baker A. Srinivasan A, et al. J Pediatr Hematol Oncol. 2019 May;41(4):334-335. doi: 10.1097/MPH.0000000000001446. J Pediatr Hematol Oncol. 2019. PMID: 30807397 No abstract available.

2

A diagnostically difficult case of chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA effectively treated with imatinib in accelerated phase: case report.

Rodzaj M, Gałazka K, Majewski M, Zduńczyk A. Rodzaj M, et al. Pol Arch Med Wewn. 2009 Dec;119(12):838-41. Pol Arch Med Wewn. 2009. PMID: 20010473 Free article.

3

Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy.

Barraco D, Carobolante F, Candoni A, Simeone E, Piccaluga P, Tabanelli V, Fanin R. Barraco D, et al. Eur J Haematol. 2014 Jun;92(6):541-5. doi: 10.1111/ejh.12272. Epub 2014 Feb 19. Eur J Haematol. 2014. PMID: 24460680

4

Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.

Pardanani A, Lasho T, Barraco D, Patnaik M, Elala Y, Tefferi A. Pardanani A, et al. Am J Hematol. 2016 Mar;91(3):E10-1. doi: 10.1002/ajh.24273. Epub 2016 Jan 11. Am J Hematol. 2016. PMID: 26663400 Free article. No abstract available.

5

Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy.

Srinivas U, Barwad A, Pubbaraju SV. Srinivas U, et al. Br J Haematol. 2014 Jun;165(5):583. doi: 10.1111/bjh.12742. Epub 2014 Jan 24. Br J Haematol. 2014. PMID: 24456122 Free article. No abstract available.

6

A case of nonleukemic myeloid sarcoma with FIP1L1-PDGFRA rearrangement: an unusual presentation of a rare disease.

Chen D, Bachanova V, Ketterling RP, Begna KH, Hanson CA, Viswanatha DS. Chen D, et al. Am J Surg Pathol. 2013 Jan;37(1):147-51. doi: 10.1097/PAS.0b013e31826df00b. Am J Surg Pathol. 2013. PMID: 23232855

7

Imatinib therapy in a patient with suspected chronic neutrophilic leukemia and FIP1L1-PDGFRA rearrangement.

Jain N, Khoury JD, Pemmaraju N, Kollipara P, Kantarjian H, Verstovsek S. Jain N, et al. Blood. 2013 Nov 7;122(19):3387-8. doi: 10.1182/blood-2013-07-516500. Blood. 2013. PMID: 24203930 Free article. No abstract available.

8

Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript.

Helbig G, Soja A, Świderska A, Hus M, Kyrcz-Krzemień S. Helbig G, et al. Leuk Lymphoma. 2016;57(3):708-10. doi: 10.3109/10428194.2015.1065983. Epub 2015 Oct 2. Leuk Lymphoma. 2016. PMID: 26430910 No abstract available.

9

FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells.

Crescenzi B, Chase A, Starza RL, Beacci D, Rosti V, Gallì A, Specchia G, Martelli MF, Vandenberghe P, Cools J, Jones AV, Cross NC, Marynen P, Mecucci C. Crescenzi B, et al. Leukemia. 2007 Mar;21(3):397-402. doi: 10.1038/sj.leu.2404510. Epub 2007 Jan 11. Leukemia. 2007. PMID: 17215855

10

Detection of FIP1L1-PDGFRA fusion by FISH.

Ma ES, Wong KF, Wong CL, Siu LL. Ma ES, et al. Br J Haematol. 2007 Aug;138(3):279. doi: 10.1111/j.1365-2141.2007.06637.x. Epub 2007 Jun 3. Br J Haematol. 2007. PMID: 17542982 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year